66-02-4Relevant articles and documents
Exploring the tetrahydroisoquinoline thiohydantoin scaffold blockade the androgen receptor as potent anti-prostate cancer agents
Xu, Xi,Ge, Raoling,Li, Lei,Wang, Jubo,Lu, Xiaoyu,Xue, Siqi,Chen, Xijing,Li, Zhiyu,Bian, Jinlei
, p. 1325 - 1344 (2017/11/13)
Prostate cancer (PC) is a major cause of cancer-related male death in worldwide and the identification of new and improved potent anti-PC molecules is constantly required. A novel scaffold of tetrahydroisoquinoline thiohydantoin was rationally designed based on the enzalutamide structures and our pre-work, leading to the discovery of a series of new antiproliferative compounds. Several new analogues displayed improved androgen receptor (AR) antagonistic activity, while maintaining the higher selective toxicity toward LNCaP cells (AR-rich) versus DU145 cells (AR-deficient) compared to enzalutamide. In fact, compound 55 exhibited promising in vitro antitumor activity by impairing AR unclear translocation. More importantly, 55 showed better pharmacokinetic properties compared to the compound 1 reported in our pre-work. These results demonstrate a step towards the development of novel and improved AR antagonists.
Regioselective iodination of tyrosine in a liquid membrane system, in the presence of crown ether type macrocyclic ligands. I obtention of monoiodotyrosine
Luca, Constantin,Zarna, Adriana,Anghel, Dan,Constantinescu, Titus
, p. 125 - 130 (2007/10/03)
The experiments performed have shown that, when using a "liquid membrane" system (aqueous phase source containing KI + I2 K+I3-, the receiving aqueous phase containing tyrosine, the "liquid membrane" being represented by dichloroethane, which contains the crown ether CE =18-crown-6), the selective iodination of tyrosine can be controlled so as to obtain, after four hours, monoiodotyrosine with a 100% yield.
Thyroidal biosynthesis of iodothyronines. I. General characteristics and distribution of the bovine enzyme system.
Fischer,Schulz,Oliner
, p. 4338 - 4343 (2007/10/05)
-